IP Library Granted Patent US 8,476,036
Granted Patent B2
US 8,476,036 · App. 12/494,100 · Granted Jul 2, 2013

Nonluminogenic assay for living cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,476,036
App. No.
12/494,100
Granted
Jul 2, 2013
Kind
B2
Abstract

A method to detect the presence or amount of at least one molecule for an enzyme-mediated reaction in a multiplex luminogenic/nonluminogenic assay is provided.

Claims (20)

1. A method to quantify live cells in a sample, comprising:

a) contacting a sample comprising live cells and dead cells with a fluorogenic substantially live cell permeable substrate for (i) a protease associated with a proteasome, (ii) an aminopeptidase or (iii) a cathepsin; and

b) detecting or determining total fluorescence in the sample comprising live cells and dead cells, wherein the total fluorescence is proportional to the number of live cells, thereby quantifying the number of live cells in the sample;

wherein the protease associated with the proteasome, the aminopeptidase or the cathepsin is substantially inactive when present in an extracellular environment.

2. The method of claim 1 wherein the substrate is Gly-Phe-AFC, Gly-Phe-AMC, Gly-Gly-Leu-AMC, Z-Gly-Gly-Leu-AMC, Phe-AMC, or Tyr-AMC.

3. The method of claim 1 wherein the sample is contacted with the substrate for the protease associated with a proteasome.

4. The method of claim 3 wherein the protease associated with a proteasome is substantially inactive when present in an extracellular environment.

5. The method of claim 1 wherein the sample is contacted with the substrate for the aminopeptidase.

6. The method of claim 5 wherein the aminopeptidase is substantially inactive when present in an extracellular environment.

7. The method of claim 1 wherein the sample is contacted with the substrate for the cathepsin.

8. The method of claim 7 wherein the cathepsin is substantially inactive when present in an extracellular environment.

9. A method to quantify live cells in a sample, comprising:

a) contacting a sample with a fluorogenic substantially live cell permeable substrate for (i) a protease associated with a proteasome, (ii) an aminopeptidase or (iii) a cathepsin; and

b) detecting or determining total fluorescence in the sample, wherein the total fluorescence is proportional to the number of live cells, thereby quantifying the number of live cells in the sample;

wherein the protease associated with the proteasome, the aminopeptidase or the cathepsin is substantially inactive when present in an extracellular environment.

10. The method of claim 9 wherein the substrate is Gly-Phe-AFC, Gly-Phe-AMC, Gly-Gly-Leu-AMC, Z-Gly-Gly-Leu-AMC, Phe-AMC, or Tyr-AMC.

11. The method of claim 9 wherein the sample is contacted with the substrate for the protease associated with a proteasome.

12. The method of claim 9 wherein the sample is contacted with the substrate for the aminopeptidase.

13. The method of claim 9 wherein the sample is contacted with the substrate for the cathepsin.

14. The method of claim 9 wherein the sample in step b comprises live cells and dead cells.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: NILES, ANDREW; RISS, TERRY L.
To: PROMEGA CORPORATION
Reel/Frame 033211/0588 →